# Telehealth Privacy — Workflows ## Workflow 1: Telehealth Platform Compliance Evaluation ``` Evaluating Telehealth Platform for HIPAA Compliance │ ├── Step 1: BAA Assessment │ ├── Does the vendor offer a Business Associate Agreement? │ │ ├── YES → Review BAA for all required provisions (§164.504(e)(2)) │ │ └── NO → Platform is NOT compliant for HIPAA telehealth │ │ (Exception: OCR enforcement discretion expired August 2023) │ │ │ └── Is BAA executed before any PHI transmission? │ ├── Step 2: Technical Safeguards Evaluation │ │ │ ├── Encryption │ │ ├── End-to-end encryption for video/audio/data? (minimum AES-128; AES-256 preferred) │ │ ├── TLS 1.2+ for signaling and control channels? │ │ ├── SRTP for media streams? │ │ └── No unencrypted fallback? │ │ │ ├── Access Controls │ │ ├── Unique user authentication for providers? │ │ ├── Patient identity verification process? │ │ ├── Session-level access controls (each session separate)? │ │ ├── Automatic session termination on disconnect/inactivity? │ │ └── MFA for provider access? │ │ │ ├── Audit Controls │ │ ├── Session logging (initiation, connection, participants, duration)? │ │ ├── Recording access logs? │ │ ├── Log retention (minimum 6 years)? │ │ └── Tamper-resistant logs? │ │ │ └── Integrity │ ├── Tamper-evident session metadata? │ └── Digital signatures on stored encounters? │ ├── Step 3: Data Handling │ ├── Where is data stored (geographic location)? │ ├── How long are recordings retained? │ ├── Data deletion/retention policies? │ └── Data portability (can entity retrieve data at termination)? │ └── Step 4: Approval Decision ├── All criteria met → Approved for clinical telehealth ├── Deficiencies identified → Remediation required before approval └── Document evaluation results and approval ``` ## Workflow 2: Telehealth Encounter Privacy Protocol ``` Telehealth Visit Initiated │ ├── Pre-Visit │ ├── Provider confirms private room with closed door │ ├── Provider ensures no visible patient information behind camera │ ├── Provider uses headphones/earbuds │ ├── Provider uses only approved/managed device │ └── System verifies platform is BAA-covered │ ├── Visit Start │ ├── Provider authenticates to platform (MFA) │ ├── Patient authenticates (portal credentials or identity verification) │ ├── System prompts: Confirm patient's physical location (state) │ │ └── Apply location-specific consent and recording requirements │ │ │ ├── Recording Consent (if applicable) │ │ ├── Is patient in a two-party consent state? │ │ │ ├── YES → Display recording notice; require affirmative consent │ │ │ │ ├── Patient consents → Enable recording │ │ │ │ └── Patient declines → Proceed without recording │ │ │ └── NO → Display notice; one-party consent sufficient │ │ └── Document consent decision │ │ │ └── Privacy notice displayed to patient: │ "This visit is conducted on a secure, HIPAA-compliant platform. │ [Recording notice if applicable]" │ ├── During Visit │ ├── Maintain encrypted connection throughout │ ├── Provider documents in EHR (same clinical standards as in-person) │ ├── If connection drops: re-authenticate before resuming │ ├── If prescribing controlled substances: │ │ ├── Verify provider licensed in patient's state │ │ ├── Check state PDMP │ │ └── Apply Ryan Haight Act requirements │ └── Screen sharing: ensure no other patient data visible │ ├── Visit End │ ├── Provider terminates session │ ├── System confirms session ended on all endpoints │ ├── Session metadata logged (duration, participants, location) │ └── Recording (if any) encrypted and stored in EHR document management │ └── Post-Visit ├── Clinical documentation completed in EHR ├── Prescriptions transmitted via e-prescribing (HIPAA-compliant) ├── Follow-up communications via secure messaging (patient portal) └── Recording access restricted to care team and authorized reviewers ``` ## Workflow 3: Remote Patient Monitoring Privacy Setup ``` RPM Program Enrollment │ ├── Step 1: Vendor/Platform Assessment │ ├── RPM platform vendor has BAA in place? │ ├── Device-to-cloud communication encrypted? │ ├── Cloud platform meets HIPAA Security Rule? │ └── Data integration with EHR is secure (FHIR API + OAuth 2.0)? │ ├── Step 2: Patient Enrollment and Consent │ ├── Explain data collection scope (what data, how often) │ ├── Explain who accesses data (care team, monitoring center, BA) │ ├── Explain how data is used (clinical, AI analytics, quality) │ ├── Explain patient's right to pause or stop monitoring │ ├── Explain security measures │ ├── Explain limitations (not emergency services) │ ├── Obtain written informed consent │ └── Document consent in EHR │ ├── Step 3: Device Configuration │ ├── Configure device with patient-specific encryption keys │ ├── Enable minimum necessary data collection only │ ├── Configure secure transmission schedule │ ├── Register device in asset management system │ └── Provide patient with setup instructions and privacy tips │ ├── Step 4: Ongoing Monitoring │ ├── Data flows securely to EHR/monitoring platform │ ├── Alerts and notifications minimize PHI content │ ├── Regular data quality checks │ ├── Quarterly consent review with patient │ └── Device firmware updates managed securely │ └── Step 5: Disenrollment ├── Patient requests disenrollment or program ends ├── Data collection ceases ├── Device returned or wiped (NIST SP 800-88) ├── Historical data retained in EHR per retention policy └── Consent status updated in EHR ```